{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-125282","form_type":"8-K","ticker":"INMB","cik":"0001711754","company_name":"Inmune Bio, Inc.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.233218+00:00","generated_at":"2026-05-16T12:16:20.308086+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"INmune Bio amends 1.35M April 2024 warrants; exercise price cut to $1.95, term extended to June 2026","bullets":["Exercise price of 1,348,315 outstanding April 2024 warrants reduced to $1.95 per share.","Warrant term extended to expire on June 30, 2026 (from earlier conditional triggers).","Holders paid $0.05 per warrant ($67,416 total) as amendment consideration.","Warrants were originally issued in April 2024 offerings (April 24 & 29, 2024).","Amendment effective upon receipt of signed amendment and full consideration."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-125282","json":"https://secwatch.observer/filing/0001213900-25-125282.json","markdown":"https://secwatch.observer/filing/0001213900-25-125282.md","text":"https://secwatch.observer/filing/0001213900-25-125282.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/0001213900-25-125282-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/ea0270723-8k_inmune.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:16:20.308086+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e177189dbfd351ede39c81043296015d54f60ce7","claim":"Inmune Bio, Inc. amended Warrant Amendment with certain holders of warrants previously issued by the Company valued at $0.05 per April 2024 Warrant, for aggregate proceeds of $67,416 (effective 2025-12-22).","evidence_excerpt":"On December 22, 2025, INmune Bio Inc. (the “Company”) entered into an amendment (the “Warrant Amendment”) with certain holders of warrants previously issued by the Company in its April 2024 offerings","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390025125282/0001213900-25-125282-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"certain holders of warrants previously issued by the Company"},{"label":"Value","value":"$0.05 per April 2024 Warrant, for aggregate proceeds of $67,416"},{"label":"Effective","value":"2025-12-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}